Management of severe polyuria in idiopathic Fanconi syndrome

Pediatr Nephrol. 2021 Nov;36(11):3621-3626. doi: 10.1007/s00467-021-05213-6. Epub 2021 Aug 24.

Abstract

Background: Polyuria is a common problem in patients with tubular diseases, especially for those with CKD and high-output Fanconi syndrome. There are currently no guidelines on how to treat debilitating polyuria, in children or adults, and vasopressin is usually not effective.

Case-diagnosis/treatment: A 13-year-old female with idiopathic Fanconi syndrome and an eGFR of 69 mL/min/1.73 m2 was severely affected by polyuria of 5 L per day (voiding at least 11 times during the day and up to 8 times at night), impacting her mood (measured by the RCADS-child) and academic performance at school. In the absence of guidelines and with literature discouraging the use of indomethacin in this condition, we attempted indomethacin treatment at a dose of 2 mg/kg divided in two doses with substantial success. Urine output dropped to 2.5L and this was accompanied by a substantial decrease of her sodium wasting from 24.6 to 7.7 mmol/kg/day. Over the course of 18 months, the patient's eGFR dropped temporarily to 60 mL/min/1.73 m2 and was 68 mL/min/1.73 m2 at last follow-up. However, a sodium-23 (23Na) MRI of her thigh revealed ongoing moderate sodium decrease in her skin and substantial Na+ decrease in her muscle when compared to age-matched peers with normal kidney function.

Conclusions: Indomethacin may be a safe and effective treatment option for polyuria in idiopathic Fanconi syndrome.

Keywords: Academic performance; Fanconi syndrome; Indomethacin; Mood and quality of life; Polyuria; Sodium-23 (23Na) MRI; Tubular defect; Reduction of free water clearance.

Publication types

  • Case Reports

MeSH terms

  • Adolescent
  • Fanconi Syndrome* / complications
  • Female
  • Humans
  • Indomethacin / therapeutic use
  • Polyuria* / drug therapy
  • Polyuria* / physiopathology
  • Severity of Illness Index

Substances

  • Indomethacin